Bhanzu

https://academic.oup.com › rheumatology › article
Secukinumab versus adalimumab for treatment of active psoriatic arthritis EXCEED a double blind parallel group randomised active controlled phase 3b trial a multicentre

https://clinicaltrials.gov › study
Secukinumab versus adalimumab for treatment of active psoriatic arthritis EXCEED a double blind parallel group randomised active controlled phase 3b trial

https://rheumnow.com › content › exceed-study-cosentyx-equals-humira...
Novartis has announced the results of the EXCEED trial that pitted its IL 17 inhibitor Cosentyx secukinumab SEC against Humira adalimumab ADA in patients with active psoriatic

https://www.nejm.org › doi › full
In two phase 3 double blind 52 week trials ERASURE Efficacy of Response and Safety of Two Fixed Secukinumab Regimens in Psoriasis and FIXTURE Full Year Investigative

https://www.novartis.com › news › media-releases › novartis-cosentyx...
EXCEED is the first double blinded head to head clinical trial evaluating Cosentyx secukinumab 300 mg versus Humira adalimumab 40 mg EXCEED is a 52 week multi center

https://link.springer.com › article
Introduction Studies evaluating the long term comparative efficacy between biologic therapies for psoriatic arthritis PsA are scarce Two biologic therapies guselkumab and

https://ard.bmj.com › content
Background Psoriatic arthritis PsA is a heterogeneous disease comprising musculoskeletal and dermatological manifestations especially plaque psoriasis 1 Secukinumab SEC an IL 17A

https://www.biospace.com › novartis-cosentyx-narrowly-misses-beating...
Novartis announced results from its EXCEED clinical trial comparing its Cosentyx secukinumab to AbbVie s bestselling Humira adalimumab in patients with active psoriatic arthritis

https://acrabstracts.org › abstract › comparison-of-secukinumab-versus...
Background Purpose Lower efficacy to anti tumor necrosis factor treatment has been reported in female patients with psoriatic arthritis PsA as compared to males in clinical registries 1 The EXCEED study